Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reza Boostani

Showing results (91-100 of 119) with videos related to

Pageof 12
Sort By:
BMC Neurology|June 21, 2024
DOK7 congenital myasthenic syndrome: case series and review of literatureBentolhoda Ziaadini, Bardyia Ghaderi Yazdi, Elham Dirandeh, et al.
Cytokine|December 4, 2024
Effects of probiotics on clinical manifestations and inflammatory markers in HTLV-1-associated myelopathy/tropical spastic paraparesis: A triple blind randomized, placebo controlled trialParvaneh Mamaghani Rad, Zohreh Vahidi, Mostafa Zemorshidi, et al.
Archives of Iranian Medicine|February 7, 2022
Iranian Consensus Recommendations for Treatment of Myasthenia GravisShahriar Nafissi, Ali Asghar Okhovat, Farnaz Sinaei, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|September 14, 2012
Inter-rater reliability of modified Alberta Stroke program early computerized tomography score in patients with brain infarctionKavian Ghandehari, Mohammad Reza Rezvani, Mohammad Taghi Shakeri, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 30, 2016
Modulatory effects of curcumin on apoptosis and cytotoxicity-related molecules in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patientsAsadollah Mohammadi, Bahare Fazeli, Marzieh Taheri, et al.
Journal of Neurovirology|October 23, 2023
Immune response to COVID-19 vaccines among people living with human T-cell lymphotropic virus type 1 infection: a retrospective cohort study from IranReza Jafarzadeh Esfehani, Zohreh Vahidi, Mohammad Shariati, et al.
Advances in Experimental Medicine and Biology|January 4, 2022
Nanomicellar Curcumin Supplementation Improves the Clinical Manifestations of HAM/TSP PatientsAsadollah Mohammadi, Shadi Zamanian Yazdi, Zohreh Poursina, et al.
Frontiers in Neurology|September 13, 2021
Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab BiosimilarFarzad Fatehi, Kamyar Moradi, Ali Asghar Okhovat, et al.
Microbial Pathogenesis|December 26, 2022
XCL1, a serum biomarker in neurological diseases; HTLV-1-associated myelopathy and multiple sclerosisMorteza Saeidi, Zohreh Vahidi, Mohammad Ali Nahayati, et al.
Basic and Clinical Neuroscience|February 17, 2022
Guillain-Barre Syndrome and COVID-19 Vaccine: A Report of Nine PatientsNarges Karimi, Reza Boostani, Farzad Fatehi, et al.
Pageof 12

Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
BMC Neurology|June 21, 2024
DOK7 congenital myasthenic syndrome: case series and review of literatureBentolhoda Ziaadini, Bardyia Ghaderi Yazdi, Elham Dirandeh, et al.
Cytokine|December 4, 2024
Effects of probiotics on clinical manifestations and inflammatory markers in HTLV-1-associated myelopathy/tropical spastic paraparesis: A triple blind randomized, placebo controlled trialParvaneh Mamaghani Rad, Zohreh Vahidi, Mostafa Zemorshidi, et al.
Archives of Iranian Medicine|February 7, 2022
Iranian Consensus Recommendations for Treatment of Myasthenia GravisShahriar Nafissi, Ali Asghar Okhovat, Farnaz Sinaei, et al.
Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences|September 14, 2012
Inter-rater reliability of modified Alberta Stroke program early computerized tomography score in patients with brain infarctionKavian Ghandehari, Mohammad Reza Rezvani, Mohammad Taghi Shakeri, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 30, 2016
Modulatory effects of curcumin on apoptosis and cytotoxicity-related molecules in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patientsAsadollah Mohammadi, Bahare Fazeli, Marzieh Taheri, et al.
Journal of Neurovirology|October 23, 2023
Immune response to COVID-19 vaccines among people living with human T-cell lymphotropic virus type 1 infection: a retrospective cohort study from IranReza Jafarzadeh Esfehani, Zohreh Vahidi, Mohammad Shariati, et al.
Advances in Experimental Medicine and Biology|January 4, 2022
Nanomicellar Curcumin Supplementation Improves the Clinical Manifestations of HAM/TSP PatientsAsadollah Mohammadi, Shadi Zamanian Yazdi, Zohreh Poursina, et al.
Frontiers in Neurology|September 13, 2021
Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab BiosimilarFarzad Fatehi, Kamyar Moradi, Ali Asghar Okhovat, et al.
Microbial Pathogenesis|December 26, 2022
XCL1, a serum biomarker in neurological diseases; HTLV-1-associated myelopathy and multiple sclerosisMorteza Saeidi, Zohreh Vahidi, Mohammad Ali Nahayati, et al.
Basic and Clinical Neuroscience|February 17, 2022
Guillain-Barre Syndrome and COVID-19 Vaccine: A Report of Nine PatientsNarges Karimi, Reza Boostani, Farzad Fatehi, et al.
Pageof 12